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Abstract
The South African Department of Health adopted numerous strategies to manage the 
HIV epidemic. Recently, the global 90-90-90 HIV treatment strategy was adopted. This 
strategy hope to ensure that 90% of people living with HIV will know their status, 90% 
of those testing HIV positive will receive sustained antiretroviral therapy and 90% of 
those receiving antiretroviral therapy will reach and maintain viral suppression by 2020. 
With a focus on literature, policies and implementation interventions, this chapter aims 
to provide an overview on current strategies used to reach the 90-90-90 goals and dis-
cusses how these strategies can be strengthened among sero-discordant couples within 
the South African public health system.
Keywords: sero-discordance, couples-counselling and testing, safe conception, 
behavioural interventions, treatment and adherence, gender norms, sexual health rights
1. Introduction
The burden of HIV has long plagued Sub-Saharan Africa [1]. Since the start of the epidemic, 
three decades ago, the country has made significant progress in managing the disease [2]. 
Over the last 10 years South Africa has successfully implemented HIV prevention and treat-
ment strategies, informed by empirical research. Despite the gains made, incidence contin-
ues to increase given several socio-behavioural factors associated with HIV transmission 
[3–5]. Additionally, with an estimated 469,000 new infections noted in 2012, an increase in 
sero-discordant relationships can be anticipated [4]. It is therefore imperative to strengthen 
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sero-discordant interventions as a response to managing the HIV epidemic among couples 
that goes beyond couple testing [6].
2. Definition and prevalence of sero-discordance globally, SADC 
and SA
In sub-Saharan Africa, sero-discordance is a critical factor for the transmission of HIV [7]. 
Sero-discordance, refers to couples with a mixed HIV status. In such relationships one partner 
has a known HIV positive status while his or her partner is HIV negative [8, 9]. Hence, for the 
purpose of this chapter, we define a sero-discordant couple as two individuals who are in a 
current sexual relationship in which both partners are aware of the other’s HIV status. Some 
authors have argued that sero-discordant sexual relationships are high risk as HIV transmis-
sion is more likely to happen in longer-term relationships [10–12].
Despite the misconception that a greater proportion of men are likely to be the index partner, 
through a systematic review Eyawo et al. [13] established that nearly half (47%) of the index 
partners were women. This indicates that men and women are equally likely to be the index 
partner in sero-discordant couples in the sub-Saharan African region. These findings also 
speak to the prevention and marketing strategies that are meant to be gender balanced in 
heterosexual sero-discordant couples.
In regions with high HIV prevalence, proportions of sero-discordant intra-couple trans-
mission range from 13.0 to 55% of new HIV infections [14]. For South Africa, the estimated 
proportion of sero-discordant couples is unclear, however, transmission among longer-term 
couples were estimated above 10.0% per year [15]. Thus the prevention of intra-couple HIV 
transmission may delay the progression of the epidemic. As such, sero-discordant couples are 
a key target population in the context of HIV prevention.
3. Policies and policy implementation
South Africa has been very vigilant in the fight against HIV. For the last 20 years policy adop-
tion and implementation has been at the foreground of HIV management. This section pro-
vides an overview of policy strategies that guide HIV management and discuss how these 
strategies influence the well-being of sero-discordant couples.
Since the start of the new millennium, the management of HIV was spearheaded by compre-
hensive, multi-sectorial action orientated National Strategic Plans for HIV/AIDS and Sexually 
Transmitted Infections [15]. Over the last 18 years, many gains have been made in curbing the 
HIV epidemic. Initiated by the health ministry in 1999 the NSP 2000–2005, in partnership with 
governmental and non-governmental organisations, as well as, community- and faith-based 
organisations priority areas related to HIV management were identified. The outcome of this 
discussion produced four key focus areas.
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These included a focus on:
• Prevention;
• Treatment, care and support;
• Research, monitoring, and surveillance;
• Human rights and access to justice.
In essence, the NSP 2000–2005 garnered immense progress in the fight against HIV, but 
aetiological differences regards the epidemic between the government and civil society posed 
numerous challenges that curbed the progress [15]. Informed by the successes and limitations 
of the NSP 2000–2005, in addition to, the progress of the disease and the gains made in terms 
of biomedical advances, the NSP 2007–2011 continued to focus on improving prevention; 
treatment, care and support; research, monitoring, and surveillance; human rights and access 
to justice. Some primary goals were attached to each of these key priority areas. In terms of 
prevention, the goal was to decrease new infections by 50% with a focus on the 15–24 age year 
group. Even though this goal was not attained, the mother-to-child transmission was signifi-
cantly reduced [16]. The treatment focused goal aimed to facilitate access to the appropriate 
HIV treatment to 80% of PLHIV by the end of the 5 year period. With some challenges regard-
ing implementation, monitoring and evaluation, the decrease in the general adult mortality 
rates could be accredited to the increase in treatment access [16]. The third and fourth priority 
areas were reportedly riddled with implementation barriers and therefore did not reach all 
its goals. It can therefore be established that the second NSP (2007–2011) made some gains 
in managing HIV, but much more needs to be done at the structural level to ensure greater 
success.
The NSP 2012–2016, introduced a comprehensive response, which included goals and tar-
gets, linked to treatment, prevention, human rights and TB. While many goals were achieved 
during the 2012–2016 period, gaps were also identified. For instance, notable declines were 
reported in terms of reducing new HIV and TB infections, but the goal to reduce new HIV 
infections and new TB infections by at least 50% has not been achieved. What has become 
evident is that reducing incidence and stabilising prevalence, will require the scale-up of HIV/
TB prevention, testing, linkage to care and life-long adherence strategies, with a particular 
focus on high risk populations.
Two years prior to the end of the NSP 2012–2016 term, South Africa adopted the global 90-90-
90 treatment strategy. With its focus on treatment, the strategy targets aims to facilitate the 
necessary processes so that 90% of people living with HIV can know their status, 90% of those 
who tested HIV positive can receive sustained antiretroviral therapy and that 90% of those 
receiving antiretroviral therapy reach and maintain viral suppression by 2020 (see Figure 1).
According to Bain et al. [17] the success of the strategy would “… result in 73% of people with 
HIV achieving viral suppression, a crucial step in ending the AIDS epidemic by 2030 “(p. 1). 
With this strategy in place, the South African National AIDS Council (SANAC) [18] recently 
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reported that among adults aged 15–59 years old, 86.0% were aware of their HIV status, of 
those 65.0% were currently on treatment, while of those who are on treatment 81% were 
virally suppressed (see Figure 2).
The current 2017–2022 NSP proposes a focus on social and behavioural aspects of HIV/AIDS 
and TB that prioritises a research agenda. This includes a commitment to having dedicated 
research funding for these health issues, build capacity to conduct research, and to identify 
better ways to collect and disseminate research findings. In addition, the plan acknowledges 
that we cannot simply treat our way out of the HIV epidemic, but that prevention strategies 
would offer the best response to curbing the HIV and TB epidemic.
While the NSP 2017–2022 stipulates the importance of Social Science and Humanities research 
in the 5 year plan, the proposed research foci continue to hover around understanding the 
Figure 1. Key targets of the 90-90-90 HIV treatment strategy.
Figure 2. Progress towards the 90-90-90 HIV treatment strategy.
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social determinants of HIV and TB. Because of the changing nature of the epidemics, research 
on social determinants will always be relevant. However, at this stage in the fight against 
HIV and TB, developing and testing robust behavioural intervention models should be at the 
foreground of our national HIV/TB response. Furthermore, what the current NSP lacks is a 
clear strategy that marries bio-medical and socio-behavioural models to improve the HIV/
TB-related outcomes for the country.
For instance, with 6.8 mil PLHIV, more comprehensive work should be prioritised. An 
example of such work could include a socio-behavioural intervention among sero-discordant 
couples. The NSP highlights a focus on family, but fail to clearly define possible intervention 
entry points that could help achieve the 90-90-90 goals within the family. A family- or couple-
focused intervention may include encouraging home-based testing, family participation in 
achieving adherence and ultimately viral suppression.
4. Existing prevention interventions for sero-discordant couples
This section provides an overview of existing prevention and intervention programmes, that 
are implemented in the public and private health care systems as well as those implemented 
by civil society organisations.
4.1. Current couple-centred HIV prevention services
The prevalence of sero-discordance among romantic relationships is growing in South Africa 
for various reasons [6]. What is concerning is the fact that, in the country and globally, it has 
been documented that HIV is most commonly transmitted between partners who are in a com-
mitted relationship [6]. This ultimately raises important issues including the risk of infection, 
reproductive choices and stress and change in the relationship dynamics. Despite the salience 
of couple relationships, existing HIV prevention interventions mainly focus on individuals 
instead of couples as a unit [19]. This negates the significant influence that couples play on 
each other’s behaviour. There is growing agreement on the fact that prevention interventions 
and research should be aimed at couples as a unit to bring about change and maintain dis-
cordance. Couples-focused programs could concurrently include both dyad members, target 
each member separately and alone, in other instances might involve a combination of both 
modalities. The World Health Organisation has set out specific prevention interventions for 
couples with respect to their sero-status [20]. Figure 3 lists the interventions that are specific 
for sero-discordant couples be it whether the male or female is the index partner.
4.1.1. Case identification through HIV testing services (HTS) for couples
Paying closer attention to literature pertaining to HIV Testing Services, couples counsel-
ling and testing are especially important for identifying HIV sero-discordant status among 
couples. Many men and women who are in relationships with a partner who is HIV positive 
do not know their own HIV status let alone their partner’s [21]. In settings with a generalised 
HIV epidemic, research shows that in the context of sero-discordant relationships women 
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are especially more vulnerable to contracting the virus, due to their biological susceptibility 
as well as the infidelity of men [21]. A study conducted in a rural setting within South Africa, 
however found that HIV transmission was high among migrant men as well as migrant 
women returning to their partners. This finding suggest that there is a need to reconsider the 
premise that HIV transmission within stable relationships is attributed to extra marital sexual 
activity by men.
With this being said, HIV counselling and testing has mainly been individual based and sex-
specific. In regard to individual based prevention strategies, Jones et al. [22] implemented a 
couples HIV risk reduction intervention (called Partner Project) that included HIV Counselling 
and Testing program in 6 urban community health clinics in Lusaka, Zambia. The research-
ers found that the use sexual barrier indicators was achieved among the intervention group. 
The results also showed that there was a reduction in intimate partner violence (IPV) for the 
entire sample. IPV commonly inhibits discussions among partners regarding HIV testing, 
sero-status disclosure and condom use. Hence there should be an essential component of HIV 
prevention services that also target the reduction of IPV.
4.1.2. Treatment as prevention
In the contexts of sero-discordant couples, two broad prevention strategies with ARVs can 
be considered. Namely: antiretroviral treatment (ART) for the HIV-positive partner and pre-
exposure prophylaxis (PrEP) for the HIV-negative partner.
4.1.2.1. Antiretroviral treatment (ART) for the HIV-positive partner
The WHO HIV treatment guidelines [20, 23] recommend initiation of lifelong ART for 
individuals with a CD4 counts of 350/mm3 or lower. More recently, the WHO guidelines 
in 2013 recommended ART for all patients regardless of their CD4 count. Furthermore, for 
those who are in relationships with an HIV negative partner, the discordant partner is also 
Figure 3. Prevention strategies to reduce the risk of HIV transmission for sero-discordant couples.
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recommended to initiate treatment [24]. The utilisation of ARV to prevent HIV transmission 
thus transformed the field of comprehensive care for couples, particularly when the existing 
foundation was primarily the promotion of condom use. In an analysis conducted by Lasry 
et al. [25] who assessed the plausibility of a combination of strategies to reduce risk among 
sero-discordant couples. They established that ART initiation was the most protective strat-
egy employed. To demonstrate the effectiveness of the use of ARVs in reducing the risk of HIV 
transmission Hallal et al. [26] cites the Partners in Prevention project, among various other 
studies in their systemic review. The study was conducted across seven African countries 
namely Botswana, Kenya, Rwanda, South Africa, Tanzania, Uganda, and Zambia. The sample 
comprised of 3400 sero-discordant couples who were followed for a period of 24 months. A 
total of 349 (10.0%) started on HAART. The findings of the study showed that there was sub-
stantial (92.0%) reduction of HIV risk transmission through the utilisation of HAART [27]. An 
emerging trend is to employ strategies in combination with ART to expand the possibilities 
of interventions for sero-discordant couples [26]. In a rural setting in KwaZulu-Natal, South 
Africa, Oldenburg et al. [28] estimated the effect of ART in reducing the acquisition of HIV 
in sero-discordant couples in a HIV-hyperendemic and resource constrained setting. In the 
study, ART was delivered through primary care clinics that were primarily staffed and led 
by nurses. The researchers found that ART is highly effective in reducing HIV acquisition in 
sero-discordant couples, this is despite the constrained resources in the public health system.
4.1.2.2. Pre-exposure prophylaxis (PrEP) for the HIV-negative partner
A breakthrough for the extremely high infection rates in the SADC region is PrEP, where ARVs 
are administered to those individuals who are at risk of sexually acquiring the virus [29]. In 
the contexts of sero-discordant couples, PrEP is usually administered to the HIV-negative 
partner, before possible HIV exposure, which inadvertently reduces the risk of HIV acquisi-
tion [23]. In various forms PrEP has been tested (i.e. oral tablets, vaginal/rectal microbicides) 
or being developed as long-acting vaginal rings and intramuscular injectables [30]. In regard 
to oral PrEP, findings from the Partners PrEP Study showed that daily oral consumption of 
Tenofovir Disoproxil Fumarate/emtricitabine (TDF/FTC) reduced the acquisition of HIV-1 by 
75.0% and HSV-2 by 33.0% in heterosexual sero-discordant couples from Uganda and Kenya 
[26, 31]. Two PrEP trials, namely the FemPrEP and Vaginal and Oral Interventions to Control 
the Epidemic (VOICE), were stopped prematurely due to the futility associated with poor 
adherence [29]. An active arm of the VOICE trial also established no prevention benefit for 
oral TDF/FTC owing to poor levels of adherence [29].
In regard to vaginal gels, the CAPRISA 004 study assessed the effectiveness and safety of 1.0% 
Tenofovir gel for the prevention of HIV infection in among 889 women (aged 18–40 years, 
who were sexually active with a sero negative status) from urban and rural KwaZulu-Natal 
[31, 32]. The researchers investigated the reduction of HIV incidence against varying degrees 
of adherence. The findings of the study demonstrated that HIV incidence reduction was 54.0% 
for high adherence (gel adherence >80%), the HIV incidence was 38.0% and 28.0% lower for 
intermediate adherence (gel adherence 50–80%) and low adherence (gel adherence <50%) 
respectively. Overall, the HIV infection was reduced with Tenofovir gel at an estimated 39.0%.
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4.1.3. Tailor-made sexual health services
4.1.3.1. Voluntary medical male circumcision (VMMC) for HIV-negative male partners
VMMC has been recommended by PEPFAR and WHO, as an HIV prevention method to 
reduce the risk of HIV acquisition in generalised epidemics [30]. Evidence from South African, 
population-based data, demonstrates that there were lower HIV prevalence and incidence 
(55.0 and 65.0% lower, respectively) among circumcised men compared to uncircumcised 
men [29, 32]. Voluntary medical male circumcision is recommended, within heterosexual 
sero-discordant couples in the case where the male is the HIV-negative partner [31]. It is an 
excellent HIV prevention method, because it offers lifelong partial protection against female-
to-male sexual transmission of HIV. However, it is not recommended for HIV-positive males 
within heterosexual relationships or men who have sex with men [31]. To help increase cover-
age of VMMC, WHO recommended that all HIV-negative men in sero-discordant or concor-
dant negative couples be routinely counselled about and linked to VMMC services [30].
Several research confirming the protective effect of VMMC against HIV infection have been 
published [30, 31, 33–35]. Baeten et al. [35] conducted an observational study with 1096 
African HIV-1 sero-discordant couples in which the index partner (HIV-1 seropositive part-
ner) was male. The sample was drawn from 7 Southern African (Gaborone, Botswana; Cape 
Town, Orange Farm, and Soweto, South Africa; Kitwe, Lusaka, and Ndola, Zambia) and 7 
eastern African Africa (Eldoret, Kisumu, Nairobi and Thika, Kenya; Kigali, Rwanda; Moshi, 
Tanzania; Kampala, Uganda) sites. The results showed a non-statistically significant decrease 
in the risk of HIV-1 transmission for circumcised HIV-1 infected men to their female partners 
in comparison to couples with uncircumcised HIV-1 infected men. This finding adds to a 
limited body of data relating circumcision status in HIV-1 infected men to the risk of male- 
to-female HIV-1 transmission, data which may be helpful for programmes working to scale-
up male circumcision for HIV-1 prevention. Randomised trials from Kenya, South Africa, and 
Uganda demonstrated that male circumcision reduces a man’s risk of acquiring HIV-1 by 
approximately 60.0%.
Auvert et al. [33] conducted an experimental trial to test the efficacy of Medical circumci-
sion (MC) as a protecting factor against HIV infection among men. The study was the first 
randomised control trial, in South Africa, that aimed to test the impact of MC on health. The 
findings demonstrated MC offers a substantially high level of protection for men against 
acquiring HIV infection, this protection may be seen as effectiveness as what a vaccine of 
high efficacy would achieve [33]. Furthermore, Auvert et al. [34] continued to do research 
on medical male circumcision. They implemented the Bophelo Pele community-based HIV 
campaign (Orange Farm, South Africa). The campaign included the roll-out of free VMMC. A 
cross-sectional survey was administered with men aged 15–49 years. The results of the sur-
vey suggest that the roll-out of VMMC was associated with a reduction in the incidence and 
prevalence of HIV among circumcised men as compared to uncircumcised men. Furthermore, 
the findings also provide an argument that the uptake of VMMC is plausible and may become 
acceptable in communities that were traditionally non-circumcising communities in South 
Africa and sub-Saharan Africa [34].
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4.1.3.2. Family planning
Many sero-discordant couples have high fertility and both (infected and uninfected) partners 
often report desires of having children with their partner [36]. Pregnancy is a time of heightened 
risk of sexual transmission and acquisition of HIV. Technologically advanced options for con-
ception for sero-discordant couples include intrauterine or intravaginal insemination (of semen 
during the fertile period). Vaginal insemination is regarded as the safer method of conception 
to circumvent the sexual transmission of HIV [37]. However, it may not be accessible or afford-
able to all, especially in low to middle income countries [36, 39]. As such preconception services 
for PLHIV and their partners are prudent, and should be part and parcel of the care package 
they receive. The purpose of preconception care and counselling (PCC) for PLHIV is to ensure 
that both partners are optimally healthy, prior to pregnancy, and that the risk of HIV transmis-
sion to the partner (sexual transmission) and child (through pregnancy, delivery or breast-
feeding) are reduced [38]. Options for safer conception, that are less reliant on technology, for 
sero-discordant couples include ART for the positive partner, timed unprotected intercourse, 
and PrEP for the uninfected male partner. ART literature shows that safe conception may be 
feasible when the infected partner is virally suppressed and on ART. While fully suppressive 
ART use may significantly reduce the chance of sexual transmission, sexual HIV transmission 
may still occur [36, 37]. Limited and timed unprotected sex and –natural conception for HIV 
sero-discordant couples involves limited and timed unprotected sexual intercourse during the 
fertile periods. Women are advised to track their menstrual and ovulation cycles. Couples are 
encouraged to minimise their sexual encounters to the fertile period to decrease the number of 
unprotected sexual encounters while maximising their chance of conception [35–37].
Periconception PrEP—is an option for the HIV negative partner. The benefits for the pericon-
ception PrEP is higher adherence and lower costs due to the shorter duration of utilisation. 
It is important to establish whether periconception PrEP regimen will help lower the risk of 
couples who have decided to conceive despite known risks of transmission to partner and 
baby. While there are no trials with a particular focus on the risk of HIV transmission among 
sero-discordant complies during conception, but data drawn from the safety and efficacy of 
PrEP in future clinical trials among heterosexuals couples and trials testing drugs for PMTCT 
can offer insights [36, 38, 39].
5. Barrier and facilitators to achieving 90-90-90 among sero-
discordant couples
The possibility of sero-discordant relationships are becoming more common, given the 
improved quality of life and higher life expectancy for people living with HIV [26]. It is there-
fore imperative to expand HIV prevention efforts that target sero-discordant couples in the 
effort to reach the 90-90-90 treatment goals.
In regard to HIV testing and counselling, evidence shows that many of the prevention strate-
gies to reduce the risk of HIV transmission in couples are individual as opposed to couples 
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based. HIV testing and counselling practices, thus far, have only included one partner and 
encouraged clients to invite their partners to test for HIV. It would be ideal to provide health 
care services and feasible prevention methods for couples as a unit as opposed to individuals. 
Furthermore, it is evident that services have been gendered to favour females (e.g. who receive 
antenatal care) who are perceived to be at greater risk and to whom routine testing is encour-
aged. It may be important to expand the scope of testing for HIV among men who access health 
facilities for other health services. It may be suggested that there be more emphasis placed on 
HIV testing among males and this may speak to a need for male-centred health facilities.
In relation to treatment as prevention for sero-discordance, it was found through various 
clinical trial in South Africa that adherence to using PrEP was a major barrier [29]. This there-
fore nullifies the excellence of the approach to safeguard the uninfected partner from the 
transmission of the virus. Furthermore, some of the pre-exposure prophylaxes technologies 
are yet to be tested. And therefore it is imperative that we explore strategies to increase adher-
ence for ART for the positive partner, more importantly that we should uncover the barriers 
to adherence for PrEP utilisation.
There are barriers associated with family planning strategies for sero-discordant couples. 
These include the affordability and accessibility of intrauterine or intravaginal insemination 
technologies to aid in safe conception. Couples therefore have to rely on manual methods such 
as timed unprotected sex during fertile periods. This strategy requires health care workers and 
couples to be cautious and thorough in their actions, so as to reduce the risk of transmission.
Regardless of the existing literature on sero-discordant couples, there is still a need to conduct 
further research on treatment as prevention and sexual health services that are tailor-made 
for such couples.
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